Tech Company Financing Transactions

Myra Vision Funding Round

Cormorant Asset Management, PA MedTech VC Fund and The Capital Partnership participated in a $25 million Series B venture round for Myra Vision. The round was announced by the company on 6/26/2023.

Transaction Overview

Company Name
Announced On
6/26/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to further product development, scale manufacturing capabilities, and support first-in-human investigation of its Calibreye System, a novel treatment that aims to optimize reduction of intraocular pressure (IOP) for patients with moderate to advanced glaucoma.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1717 Dell Ave.
Campbell, CA 95008
USA
Phone
Undisclosed
Email Address
Overview
Designed to be the first-of-its-kind treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.
Profile
Myra Vision LinkedIn Company Profile
Social Media
Myra Vision Company Twitter Account
Company News
Myra Vision News
Facebook
Myra Vision on Facebook
YouTube
Myra Vision on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Chang
  Robert Chang LinkedIn Profile  Robert Chang Twitter Account  Robert Chang News  Robert Chang on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/26/2023: MVP Index venture capital transaction
Next: 6/26/2023: AltPep venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary